title: Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication.
abstract: The naturally occurring stilbene/alexin trans-resveratrol (trans-3,5, 4'-trihydroxystilbene) is a promising agent for the prevention of cancer. We investigated the effect of resveratrol on gap-junctional intercellular communication (GJIC) in WB-F344 rat liver epithelial cells because inhibition of GJIC is an important mechanism of tumor promotion. Seventeen to 50 microM resveratrol increased GJIC significantly by a factor of 1.3 compared with solvent vehicle controls, when the WB-F344 cells were exposed to resveratrol for 6 h. Most tumor promoters, including the phorbol ester TPA and the insecticide DDT, block GJIC. Resveratrol at 17-50 microM also significantly prevented down-regulation of GJIC by TPA and DDT, by a factor of 2.7 and 1.8, respectively. This recovery of GJIC from TPA inhibition was partly correlated with hindered hyperphosphorylation of Cx43. In conclusion, resveratrol was found to enhance GJIC and counteract the effects of tumor promoters on GJIC, and this is likely a mechanism that contributes to the antipromotional and anticarcinogenic properties of resveratrol.
authors.affiliation: Department of Chemistry and Life Sciences, Roskilde University, Roskilde, DK-4000, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Nielsen
authors.forename: R J
authors.initials: RJ
authors.lastname: Ruch
authors.forename: O
authors.initials: O
authors.lastname: Vang
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D002273:Carcinogens / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D002450:Cell Communication / Q000187:drug effects*; D002478:Cells, Cultured; D018031:Connexin 43 / Q000235:genetics / Q000378:metabolism; D003634:DDT / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D017629:Gap Junctions / Q000187:drug effects* / Q000378:metabolism; D007546:Isoquinolines; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D008845:Microinjections; D010766:Phosphorylation / Q000187:drug effects; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D000077185:Resveratrol; D013267:Stilbenes / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013997:Time Factors
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D002273:Carcinogens; D018031:Connexin 43; D007546:Isoquinolines; D012333:RNA, Messenger; D013267:Stilbenes; C017475:lucifer yellow; D003634:DDT; D013755:Tetradecanoylphorbol Acetate; D000077185:Resveratrol